Paritaprevir
CAS: 1216941-48-8
Rif. 3D-AP178043
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
- (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-6-[[(5-methyl-2-pyrazinyl)carbonyl]amino]-5,16-dioxo-2-(6-phenanthridinyloxy)cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
- Abt 450
- Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide, N-(cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-6-[[(5-methyl-2-pyrazinyl)carbonyl]amino]-5,16-dioxo-2-(6-phenanthridinyloxy)-, (2R,6S,12Z,13aS,14aR,16aS)-
- ABT450
Paritaprevir is an inhibitor drug that is used in the treatment of hepatitis C. It binds to the active site of the viral polymerase and blocks viral RNA synthesis. Paritaprevir has a half-life of about 3 hours and a concentration-time curve that results in an interactive response with wild-type virus, which may lead to antiviral resistance. Paritaprevir has been shown to be effective for patients with hepatic impairment, but it is not recommended for patients who are obese or have a body mass index greater than 30 kg/m2 because these conditions can increase the risk of adverse effects.
Proprietà chimiche
Richiesta tecnica su: 3D-AP178043 Paritaprevir
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
